Synovus Financial’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.84M Sell
80,581
-1,337
-2% -$48.4K 0.03% 294
2025
Q2
$2.95M Sell
81,918
-1,574
-2% -$52.1K 0.04% 279
2025
Q1
$2.6M Buy
83,492
+64,573
+341% +$2.05M 0.03% 293
2024
Q4
$483K Sell
18,919
-85,378
-82% -$2.26M 0.01% 653
2024
Q3
$2.95M Sell
104,297
-118,379
-53% -$3.28M 0.03% 319
2024
Q2
$5.87M Buy
222,676
+111,918
+101% +$3.1M 0.08% 160
2024
Q1
$3.36M Buy
110,758
+1,049
+1% +$30.9K 0.04% 257
2023
Q4
$3.08M Sell
109,709
-10,032
-8% -$276K 0.04% 250
2023
Q3
$3.25M Buy
119,741
+24,721
+26% +$734K 0.04% 251
2023
Q2
$2.92M Sell
95,020
-4,149
-4% -$141K 0.03% 280
2023
Q1
$3.57M Buy
99,169
+6,174
+7% +$229K 0.04% 235
2022
Q4
$3.68M Buy
92,995
+1,566
+2% +$65.4K 0.04% 229
2022
Q3
$3.68M Buy
91,429
+1,717
+2% +$73.3K 0.05% 209
2022
Q2
$3.77M Buy
89,712
+8,663
+11% +$355K 0.04% 213
2022
Q1
$3.16M Sell
81,049
-2,801
-3% -$110K 0.03% 253
2021
Q4
$3.34M Buy
+83,850
New +$3.26M 0.03% 251

Other funds holding RPRX